A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Clinical trial NCT06034002 · RECRUITING
Trial details
- NCT number
- NCT06034002
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2028-10-29
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.